Form 8-K - Current report:
SEC Accession No. 0001193125-15-076878
Filing Date
2015-03-04
Accepted
2015-03-04 16:34:57
Documents
2
Period of Report
2015-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d883974d8k.htm 8-K 15231
2 EXHIBIT 10.1 d883974dex101.htm EX-10.1 8113
  Complete submission text file 0001193125-15-076878.txt   24574
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 15673878
SIC: 2834 Pharmaceutical Preparations